Patents by Inventor Aihao Ding

Aihao Ding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9988421
    Abstract: The compounds of the present invention are represented by the following compounds having Formula (I) where the substituents R1-R10, X, Y, k, m, n, q, and s are as defined herein. These compounds are used in the treatment of cancer, immunologic disorders, autoimmune disorders, neurodegenerative disorders, or inflammatory disorders or for providing immunosuppression for transplanted organs or tissues.
    Type: Grant
    Filed: January 12, 2015
    Date of Patent: June 5, 2018
    Assignee: Cornell University
    Inventors: Gang Lin, Carl Nathan, Aihao Ding, Xiaojing Ma
  • Publication number: 20170121366
    Abstract: The compounds of the present invention are represented by the following compounds having Formula (I) where the substituents R1-R10, X, Y, k, m, n, q, and s are as defined herein. These compounds are used in the treatment of cancer, immunologic disorders, autoimmune disorders, neurodegenerative disorders, or inflammatory disorders or for providing immunosuppression for transplanted organs or tissues.
    Type: Application
    Filed: January 12, 2015
    Publication date: May 4, 2017
    Inventors: Gang LIN, Carl NATHAN, Aihao DING, Xiaojing MA
  • Patent number: 7427595
    Abstract: The invention is directed to compositions and methods for wound healing and controlling inflammation that involve proepithelin, with or without secretory leukocyte protease inhibitor (SLPI).
    Type: Grant
    Filed: December 12, 2003
    Date of Patent: September 23, 2008
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Jing Zhu, Aihao Ding, Carl Nathan
  • Patent number: RE49816
    Abstract: The compounds of the present invention are represented by the following compounds having Formula (I) where the substituents R1-R10, X, Y, k, m, n, q, and s are as defined herein. These compounds are used in the treatment of cancer, immunologic disorders, autoimmune disorders, neurodegenerative disorders, or inflammatory disorders or for providing immunosuppression for transplanted organs or tissues.
    Type: Grant
    Filed: June 4, 2020
    Date of Patent: January 30, 2024
    Assignee: CORNELL UNIVERSITY
    Inventors: Gang Lin, Carl Nathan, Aihao Ding, Xiaojing Ma